| http://www.w3.org/ns/prov#value | - The Health Care Cost Reduction Act of 2012 would repeal a 2.3 percent excise tax on gross sales receipts in excess of $5 million for manufacturers and importers of certain medical devices, including defibrillators, pacemakers and prosthetic limbs.
|
